Latest Secondary Market News

Page 1 of 7
Australian Bond Exchange says FY2026 marked a sharper recovery, with revenue up 47% and two consecutive quarters of positive operating cash flow. But the ASX-listed fixed-income group remains loss-making, carries $2 million of convertible-note maturities in 2027 and faces a going-concern uncertainty.
Claire Turing
Claire Turing
13 Nov 2026
Skydance delivered US$7.0 billion in pre-acquisition third-quarter revenue, but its first post-Warner Bros. Discovery update paired streaming growth with a warning on the film slate and a heavily leveraged balance sheet. The company is targeting at least US$6 billion in annualised synergies within three years.
Victor Sage
Victor Sage
10 Nov 2026
Australian Bond Exchange generated $1.68 million in positive operating cash flow in Q1 FY27, lifting cash to $1.49 million while repaying $436,000 of borrowings. The result strengthens its balance sheet, though the quarter’s cash inflows included $263,000 in government grants or tax incentives and $150,000 of interest received.
Victor Sage
Victor Sage
30 Oct 2026
Australian Bond Exchange Holdings improved revenue, reduced its annual loss and sharply cut operating cash outflow in FY2026. Yet with only A$249,000 in cash, net liabilities of A$1.43 million and A$2 million of convertible notes maturing from April 2027, the turnaround remains financially fragile.
Claire Turing
Claire Turing
30 Sept 2026
Latrobe Magnesium has secured A$8.5 million in equity funding to complete its Latrobe Valley demonstration plant and advance a proposed South Carolina magnesium project. The raising gives the company near-term funding certainty, but also brings further dilution and leaves the larger US development dependent on future capital.
Maxwell Dee
Maxwell Dee
22 Sept 2026
AI Private Opportunities Trust (ASX: AIX) has completed its first reporting period, raising $267 million and beginning deployment into high-profile private AI companies including ByteDance and Databricks.
Claire Turing
Claire Turing
27 Aug 2026
Island Pharmaceuticals has commissioned a second manufacturing run of its antiviral Galidesivir, aiming to stockpile up to 800 treatment courses by late 2026 to support rapid response to the fast-spreading Bundibugyo Ebola outbreak and biodefence efforts.
Victor Sage
Victor Sage
21 Aug 2026
Noumi Limited lifted FY26 revenue by 8.8% and adjusted operating EBITDA by 7.6%, driven by Dairy & Nutritionals' strong earnings and strategic investments in Plant-based Milks. The company faces refinancing uncertainty with $610 million convertible notes maturing in May 2027, prompting a proposed acquisition by majority shareholder Arrovest.
Victor Sage
Victor Sage
20 Aug 2026
Global X Metal Securities Australia Limited has issued a prospectus for five classes of securities tracking gold, silver, platinum, palladium, and a precious metals basket. The securities are physically backed, traded on ASX under AQUA Rules, and managed by JPMorgan Chase Bank.
Claire Turing
Claire Turing
13 Aug 2026
Global X Metal Securities Australia Limited has refreshed its prospectus for five classes of precious metals securities, maintaining physical bullion backing and ASX AQUA listing, with detailed disclosures on structure, fees, risks, and tax implications.
Claire Turing
Claire Turing
13 Aug 2026
Westpac has completed the $15.4 billion sale of its RAMS mortgage portfolio to a consortium including Pepper Money, KKR, and PIMCO, lifting its capital ratio and simplifying operations.
Victor Sage
Victor Sage
3 Aug 2026
VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for its suite of 27 ETFs on the ASX, updating investment strategies, fee structures, risk factors, and operational details.
Claire Turing
Claire Turing
20 July 2026

Browse the archive

Full archive